A carregar...
Harms and benefits of sodium-glucose co-transporter 2 inhibitors
Sodium-glucose co-transporter 2 inhibitors are oral glucose-lowering drugs that increase the urinary excretion of glucose. In patients with type 2 diabetes and cardiovascular disease they reduce all-cause mortality, cardiac mortality, rates of hospitalisation for heart failure and the progression of...
Na minha lista:
| Publicado no: | Aust Prescr |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
NPS MedicineWise
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572185/ https://ncbi.nlm.nih.gov/pubmed/33093744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18773/austprescr.2020.049 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|